John D. Deane's most recent trade in Surgery Partners Inc was a trade of 11,670 Common Stock done at an average price of $13.7 . Disclosure was reported to the exchange on June 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surgery Partners Inc | John A. Deane | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 45,922 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| NCS Multistage Holdings Inc | John D. Deane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 3,221 | 32,771 (0%) | 0% | 0 | Common Stock | |
| Surgery Partners Inc | John A. Deane | Director | Grant, award, or other acquisition of securities at price $ 23.32 per share. | 10 Jun 2025 | 6,861 | 34,252 (0%) | 0% | 23.3 | 159,999 | Common Stock |
| NCS Multistage Holdings Inc | John D. Deane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 4,339 | 29,550 (0%) | 0% | 0 | Common Stock | |
| Surgery Partners Inc | John A. Deane | Director | Grant, award, or other acquisition of securities at price $ 25.93 per share. | 06 Jun 2024 | 6,170 | 27,391 (0%) | 0% | 25.9 | 159,988 | Common Stock |
| NCS Multistage Holdings Inc | John D. Deane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,061 | 25,211 (0%) | 0% | 0 | Common Stock | |
| Surgery Partners Inc | John A. Deane | Director | Grant, award, or other acquisition of securities at price $ 38.16 per share. | 01 Jun 2023 | 4,192 | 21,221 (0%) | 0% | 38.2 | 159,967 | Common Stock |
| NCS Multistage Holdings Inc | John D. Deane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 5,153 | 21,150 (0%) | 0% | 0 | Common Stock | |
| Surgery Partners Inc | John A. Deane | Director | Grant, award, or other acquisition of securities at price $ 39.70 per share. | 20 May 2022 | 4,030 | 17,029 (0%) | 0% | 39.7 | 159,991 | Common Stock |
| NCS Multistage Holdings Inc | John D. Deane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 3,038 | 15,997 (0%) | 0% | 0 | Common Stock |